錦欣生殖(01951.HK)擬配股總籌12.68億港元 推進併購及增長戰略加快國內擴張及國際佈局
格隆匯 2 月 2日丨錦欣生殖(01951.HK)發佈公吿,2021年2月2日(交易時段前),公司與Morgan Stanley & Co. International plc(作為配售代理)訂立配售協議,據此,配售代理同意按悉數包銷基準向目前預期不少於六名獨立第三方投資者以每股15.85港元配售(或如未能配售,則由配售代理以主事人身份自行購買)8000萬股配售股份,配售股份將根據一般授權發行。
假設於本公吿日期至配售事項完成公司已發行股本不會發生任何變動,配售股份相當於公司現有已發行股本約3.29%及經發行及配發配售股份擴大的已發行股本約3.19%。假設配售股份獲悉數配售,預期配售事項的所得款項總額將為12.68億港元、所得款項淨額將約為12.5347億港元及每股配售股份的淨價將約為15.67港元。
公吿表示,儘管COVID-19疫情給整體ARS行業帶來一定挑戰,公司認為這也為公司推進併購及增長戰略提供了良好的窗口,從而把握機會加快國內擴張及國際佈局。故此,配售事項的所得款項淨額將用以併購位於中國ARS需求較高區域(如華東地區,京津冀地區,及其他較大潛力的地區)的ARS機構;併購位於海外(如東南亞及其它亞太國家)的ARS機構,以進一步擴張集團的全球佈局;及適當用於其他一般企業用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.